NARCICLASINE (BRD-K06792661)
Overview
- pert_id
- BRD-K06792661
- Name
- narciclasine
- Collection
- BIOA
- MOA
- Unknown
- Target(s)
- Unknown
- Indication(s)
- Unknown
- Phase
- Unknown
- Canonical SMILES
- O[C@H]1C=C2[C@@H](NC(=O)c3c(O)c4OCOc4cc23)[C@H](O)[C@@H]1O
- InChI key
- InChIKey=LZAZURSABQIKGB-AEKGRLRDSA-N
- InChI string
- InChI=1S/C14H13NO7/c16-6-1-5-4-2-7-13(22-3-21-7)11(18)8(4)14(20)15-9(5)12(19)10(6)17/h1-2,6,9-10,12,16-19H,3H2,(H,15,20)/t6-,9+,10+,12-/m0/s1
- Molecular formula
- C14H13NO7
- Molecular weight
- 307.255
External links
- PubChem
- 72376
- Wikipedia
- http://www.tocris.com/dispprod.php?ItemId=239525#.Uebmlo2G2So
- SEP-L1000
- BRD-K06792661
Predicted MOAs
| MOA | Probability |
|---|---|
| topoisomerase inhibitor | 0.1741 |
| PI3K inhibitor | 0.1473 |
| MEK inhibitor | 0.1422 |
| protein synthesis inhibitor | 0.1060 |
| CDK inhibitor | 0.0685 |
| glucocorticoid receptor agonist | 0.0512 |
| tubulin polymerization inhibitor | 0.0364 |
| EGFR inhibitor | 0.0330 |
| HSP inhibitor | 0.0269 |
| cyclooxygenase inhibitor | 0.0223 |
Chemical structure
